Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis or treatment of progressive multifocal leukoencephalopathy

Details for Australian Patent Application No. 2006206687 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Strah-Pleynet, Sonja; Li, Hongmei; Teegarden, Bradley; Unett, David J.; Dosa, Peter I.; Jayakumar, Honnappa

Agent FB Rice

Pub. Number AU-A-2006206687

PCT Pub. Number WO2006/078610

Priority 60/645,532 19.01.05 US

Filing date 17 January 2006

Wipo publication date 27 July 2006

International Classifications

A61K 31/415 (2006.01) - 1,2-Diazoles

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/078610 Priority application(s): WO2006/078610

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006206692-Methods for flavor enhancement

2006206682-Methods of use of dual PPAR agonist compounds and drug delivery devices containing such compounds